SCHEMBL27812412

SCHEMBL27812412

CCON(C)Cc1[nH]c(=O)[nH]c(=O)c1Cl

nearest known ligand 0.40

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ TYMP P19971 16/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8961931 0.75 TYMP (0.41) TYMP
SCHEMBL20799748 0.73 TYMP (0.50) TYMP
SCHEMBL20599912 0.73 TYMP (0.44) TYMP
SCHEMBL20599932 0.72 TYMP (0.46) TYMP
SCHEMBL3050953 0.71 TYMP (0.50) TYMP
Hydrochloric Acid SCHEMBL1691080 0.69 TYMP (0.56) TYMP
SCHEMBL20625526 0.67 TYMP (0.43) TYMP
SCHEMBL6060121 0.67 TYMP (0.52) TYMP
SCHEMBL6570517 0.65 TYMP (0.53) TYMP
SCHEMBL20599962 0.65 TYMP (0.59) TYMP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101820880-B Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient TAIHO PHARMACEUTICAL CO LTD 2012-11-14 — — CN disclosed
CN-101820880-A Therapeutic agent for inflammatory bowel disease comprising uracil derivative as active ingredient TAIHO PHARMACEUTICAL CO LTD 2010-09-01 — — CN disclosed
Send feedback